mRNA |
DMOG |
GDSC1000 |
pan-cancer |
AAC |
-0.051 |
0.1 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.081 |
0.1 |
mRNA |
Fumonisin B1 |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.1 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.1 |
mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
BRD-K75293299 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.1 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.1 |
mRNA |
SL 0101-1 |
GDSC1000 |
pan-cancer |
AAC |
0.055 |
0.1 |